Rafee Talukder

GU medical oncologist @BCMCancerCenter. Former heme/onc fellow @UWMedicine @fredhutch and IM resident @BCM_InternalMed. All tweets are my own. Proud #Girldad

[Rafee Talukder @rafee_talukder]

@HadidiSamer RIP. He was an amazing mentor and one of my primary inspiration for becoming a hematologist and oncologist

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

Deeply saddened to share that Dr. Mark Udden has passed away. He was an extraordinary mentor who shaped my career and touched countless lives through his dedication to teaching. His leadership of the ABIM Hematology Board elevated our entire field. My deepest condolences to his family and friends.

His legacy of excellence, compassion, and generosity will live on in all of us he taught. We've lost a giant in hematology
@ABIMcert @ASH_hematology @bcmhouston @BCMHemeOnc

[𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 @CParkMD]

⭐️Loved this informative talk by Dr. Hiba Khan @fredhutch . Updated table on the PARP inhibitor combination trials . Also a very thoughtful discussion for treatment escalation candidates for non-metastatic prostate cancer. @PGrivasMDPhD @EvanHallMD @MartinMaMDPhD @rafee_talukder @DRBakaloudiMD

[𝐂𝐡𝐚𝐧𝐝𝐥����𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 @CParkMD]

⭐️Dr. Scott Tykodi @fredhutch gives a masterful discussion on the only adjuvant study that was positive for RCC. He also gives an intriguing discussion of the use of NIVO/IPI for 1st line metastatic RCC with favorable risk . @PGrivasMDPhD @rafee_talukder @oncodaily

[Dimitra R. Bakaloudi MD, MS, MPA @DRBakaloudiMD]

I am delighted to share our manuscript evaluating Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI) in pts with #Urothelialcancer treated with ICIs

Thanks to our amazing team @PGrivasMDPhD @arkhaki @rafee_talukder @UW @fredhutch
https://t.co/Ut1UJYvLwh (1/7)

[𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 @CParkMD]

⭐️My good friend @PGrivasMDPhD and I talk about the importance of Mentorship in Oncology. We discuss people we admire such as Dr. Neeraj Agarwal and Dr. Monty Pal for being outstanding mentors. Also we discuss @DRBakaloudiMD journey to win the @ConquerCancerFd merit award.

@neerajaiims @montypal @rafee_talukder @koshkin85 @ShubhAgrawalMD @AmandaNizamMD @NazliDizman @crisbergerot @YLeyfman @OncLive

[Dimitra R. Bakaloudi MD, MS, MPA @DRBakaloudiMD]

Incredibly honored to receive one of the @ConquerCancerFd @ASCO merit awards and be part of this amazing group of brilliant minds ⭐️ Thankful to my mentors @PGrivasMDPhD @JLWrightMD and team @arkhaki @rafee_talukder @UW @fredhutch

[Rafee Talukder @rafee_talukder]

@TumorBoardTues @PGrivasMDPhD @IntegrityCE @JanssenUS @AstraZeneca @shilpaonc @brian_rini @DrRanaMcKay @galsky @arkhaki @tompowles1 @AmandaNizamMD @neerajaiims @AarmstrongDuke @sonpavde @arvinkgeorge @AzadOncology @jberchuck @Ecastromarcos @JonAnker1 @Prof_Nick_James @ScotNiglio @umangtalking 15/15 #TumorBoardTuesday
Extra attention & discussion for shared decision making for specific comorbidities:
🦵≥G2 neuropathy
Uncontrolled DM
Liver cirrhosis
🫘GFR <30 mL/min
Hx of autoimmune dx
💉Prior IO in localized dx
What 💉 would you use in 2L post EV+P? Next TBT?💁

[Rafee Talukder @rafee_talukder]

@TumorBoardTues @PGrivasMDPhD @IntegrityCE @JanssenUS @AstraZeneca @shilpaonc @brian_rini @DrRanaMcKay @galsky @arkhaki @tompowles1 @AmandaNizamMD @neerajaiims @AarmstrongDuke @sonpavde @arvinkgeorge @AzadOncology @jberchuck @Ecastromarcos @JonAnker1 @Prof_Nick_James @ScotNiglio @umangtalking 14/15 #TumorBoardTuesday
🧑‍🏫Which regimen for 1L aUC?
Detailed discussion of data, benefits vs risks/AEs, between patients & providers!
Education, BSC and multi-d input very important! (Pall care, PT/OT, Pharm, etc.) for optimal mgmt of AEs
Based on all 📚: EV + P SOC 1L (if fit)

[Rafee Talukder @rafee_talukder]

@PavlosMsaouel @PGrivasMDPhD @VivekSubbiah @NatureComms @FaltasLab @OAlhalabiMD @apolo_andrea @QingZhangLab @hodgeshc @drmehrarohit @neerajaiims @UroDocAsh @montypal I want to join as well!